TickerFacts.

TransMedics Group, Inc. (TMDX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$135.77M
Year ended 2025-12-31
$118.03M
Trailing 12 months to 2026-06-30
2018-12-29: -$19.47M2019-12-28: -$28.38M2020-12-31: -$24.81M2021-12-31: -$37.61M2022-12-31: -$27.96M2023-12-31: -$20.55M2024-12-31: $57.25M2025-12-31: $135.77M$135.77M
2018-12-29 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$135.77M+137.1%2026-02-24, From 2025-01-01
2024-12-31$57.25Mn/m2026-02-24, From 2024-01-01
2023-12-31-$20.55Mn/m2026-02-24, From 2023-01-01
2022-12-31-$27.96Mn/m2025-02-27, From 2022-01-01
2021-12-31-$37.61Mn/m2024-02-27, From 2021-01-01
2020-12-31-$24.81Mn/m2023-02-27, From 2019-12-29
2019-12-28-$28.38Mn/m2021-03-11, From 2018-12-30
2018-12-29-$19.47Mn/a2020-03-17, From 2017-12-31

EBITDA at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
TransMedics Group, Inc. (TMDX)2025-12-31$135.77M+137.1%
InMode Ltd. (INMD)2025-12-31$86.08M-24.0%
Axogen, Inc. (AXGN)2025-12-31-$1.19Mn/m
Integer Holdings Corp (ITGR)2025-12-31$351.93M+10.2%
Outset Medical, Inc. (OM)2025-12-31-$62.37Mn/m
Biolife Solutions Inc (BLFS)2025-12-31-$14.35Mn/m
Vaso Corp (VASO)2025-12-31-$2.03Mn/m
Ceribell, Inc. (CBLL)2025-12-31-$57.06Mn/m
Iridex Corp (IRIX)2026-01-03-$2.05Mn/m

Compare TMDX, INMD, AXGN, ITGR side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗